1,8-Diazabicyclo(5.4.0)undec-7-ene → (S)-tert-Butyl 2-(3-(4-(1-methylpiperidin-4-yl)piperazin-1-ylsulfonyl)propyl)pyrrolidine-1-carboxylate
반응식
FC1C(F)=C(F)C(F)=C(F)C=1O[S:5]([CH2:8][CH2:9][CH2:10][C@@H:11]1[CH2:15][CH2:14][CH2:13][N:12]1[C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])(=[O:7])=[O:6].[CH3:31][N:32]1[CH2:37][CH2:36][CH:35]([N:38]2[CH2:43][CH2:42][NH:41][CH2:40][CH2:39]2)[CH2:34][CH2:33]1.N12CCCN=C1CCCCC2.C(=O)(O)[O-].[Na+]>O1CCCC1.C(OCC)(=O)C>[CH3:31][N:32]1[CH2:33][CH2:34][CH:35]([N:38]2[CH2:43][CH2:42][N:41]([S:5]([CH2:8][CH2:9][CH2:10][C@@H:11]3[CH2:15][CH2:14][CH2:13][N:12]3[C:16]([O:18][C:19]([CH3:20])([CH3:21])[CH3:22])=[O:17])(=[O:6])=[O:7])[CH2:40][CH2:39]2)[CH2:36][CH2:37]1참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
(S)-tert-Butyl 2-(3-(perfluorophenoxysulfonyl)propyl)pyrrolidine-1-carboxylate (2.8 g, 6.099 mmol) and 1-(1-methylpiperidin-4-yl)piperazine (1.676 g, 9.148 mmol) were dissolved in tetrahydrofuran (40 ml), 1,8-diazabicyclo[5.4.0]undec-7-ene (2.7 ml, 18.297 mmol) was added under an inert gas and the mixture was refluxed for 2 h. Ethyl acetate and saturated sodium bicarbonate solution (50 ml of each) were added, the phases were separated and the aqueous phase was extracted with ethyl acetate (2×50 ml). The combined organic phases were washed with saturated sodium bicarbonate solution (40 ml), dried over sodium sulfate and concentrated in vacuo. The crude product was purified by column chromatography (silica gel) with ethyl acetate/methanol/methylene chloride/ammonia (25% aq) (300:100:50:1). Yield: quantitative
후처리
- temperaturethe mixture was refluxed for 2 h
- customthe phases were separated
- extractionthe aqueous phase was extracted with ethyl acetate (2×50 ml)
- washThe combined organic phases were washed with saturated sodium bicarbonate solution (40 ml)
- dry with materialdried over sodium sulfate
- concentrationconcentrated in vacuo
- customThe crude product was purified by column chromatography (silica gel) with ethyl acetate/methanol/methylene chloride/ammonia (25% aq) (300:100:50:1)
출처 및 근거
- ORD 기록
- ord-f335ffbf78ea4132a94ad5ff78a9dd92
- 출처 데이터셋
- uspto-grants-2012_02
- 특허 번호
- US08119805B2
반응 노트
불러오는 중…